Compare WhiteOak Capital Pharma and Healthcare Fund vs ICICI Prudential Healthcare Fund
WhiteOak Capital Pharma and Healthcare Fund
EquitySectoral-Pharma
ICICI Prudential Healthcare Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.74
2.07
NAV
₹16.63
₹44.81
Fund Started
16 Jan 2024
25 Jun 2018
Fund Size
₹1002.75 Cr
₹6861.20 Cr
Exit Load
-
Exit load of 1% if redeemed within 15 days.
1 Year
12.89%
2.11%
3 Year
-
19.35%
5 Year
-
13.95%
Equity
91.43%
98.91%
Cash
0.53%
1.09%
Top 10 Holdings
Name | Assets |
|---|---|
Divi's Laboratories Ltd. | 7.73% |
Sun Pharmaceutical Industries Ltd. | 6.57% |
Torrent Pharmaceuticals Ltd. | 5.78% |
Laurus Labs Ltd. | 3.61% |
Apollo Hospitals Enterprise Ltd. | 3.47% |
Cipla Ltd. | 3.40% |
Sai Life Sciences Ltd. | 3.03% |
Ipca Laboratories Ltd. | 2.66% |
Zydus Lifesciences Ltd. | 2.60% |
Neuland Laboratories Ltd. | 2.40% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.49% |
Dr. Reddy's Laboratories Ltd. | 9.73% |
Cipla Ltd. | 5.79% |
Biocon Ltd. | 5.33% |
Mankind Pharma Ltd. | 5.04% |
Alkem Laboratories Ltd. | 4.81% |
Medplus Health Services Ltd. | 4.31% |
Cohance Lifesciences Ltd. | 4.06% |
Divi's Laboratories Ltd. | 3.78% |
Syngene International Ltd. | 3.50% |
Name
-
-
Start Date
-
-
Description
The Scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
16 Jan 2024
25 Jun 2018
